These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8844419

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Sensitive liquid chromatographic-tandem mass spectrometric method for the determination of fluoxetine and its primary active metabolite norfluoxetine in human plasma.
    Sutherland FC, Badenhorst D, de Jager AD, Scanes T, Hundt HK, Swart KJ, Hundt AF.
    J Chromatogr A; 2001 Apr 20; 914(1-2):45-51. PubMed ID: 11358229
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding.
    Kim J, Riggs KW, Misri S, Kent N, Oberlander TF, Grunau RE, Fitzgerald C, Rurak DW.
    Br J Clin Pharmacol; 2006 Feb 20; 61(2):155-63. PubMed ID: 16433870
    [Abstract] [Full Text] [Related]

  • 25. Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy.
    Bolo NR, Hodé Y, Nédélec JF, Lainé E, Wagner G, Macher JP.
    Neuropsychopharmacology; 2000 Oct 20; 23(4):428-38. PubMed ID: 10989270
    [Abstract] [Full Text] [Related]

  • 26. Analysis of fluoxetine and norfluoxetine in human plasma by liquid-phase microextraction and injection port derivatization GC-MS.
    Oliveira AF, de Figueiredo EC, Dos Santos-Neto AJ.
    J Pharm Biomed Anal; 2013 Jan 25; 73():53-8. PubMed ID: 22555013
    [Abstract] [Full Text] [Related]

  • 27. Determination of fluoxetine and norfluoxetine in rat plasma by HPLC with pre-column derivatization and fluorescence detection.
    Guo X, Fukushima T, Li F, Imai K.
    Biomed Chromatogr; 2003 Jan 25; 17(1):1-5. PubMed ID: 12582998
    [Abstract] [Full Text] [Related]

  • 28. Solid-phase extraction of fluoxetine and norfluoxetine from serum with gas chromatography-electron-capture detection.
    Dixit V, Nguyen H, Dixit VM.
    J Chromatogr; 1991 Feb 15; 563(2):379-84. PubMed ID: 2056002
    [Abstract] [Full Text] [Related]

  • 29. Liquid chromatographic-mass spectrometric method for the determination of fluoxetine and norfluoxetine in human plasma: application to clinical study.
    Djordjevic S, Kovacevic I, Miljkovic B, Vuksanovic J, Pokrajac M.
    Farmaco; 2005 Apr 15; 60(4):345-9. PubMed ID: 15848211
    [Abstract] [Full Text] [Related]

  • 30. Simultaneous determination of fluoxetine and norfluoxetine enantiomers using isotope discrimination mass spectroscopy solution method and its application in the CYP2C9-mediated stereoselective interactions.
    Yu L, Wang S, Jiang H, Zhou H, Zeng S.
    J Chromatogr A; 2012 May 04; 1236():97-104. PubMed ID: 22436668
    [Abstract] [Full Text] [Related]

  • 31. Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry.
    Eap CB, Bouchoux G, Amey M, Cochard N, Savary L, Baumann P.
    J Chromatogr Sci; 1998 Jul 04; 36(7):365-71. PubMed ID: 9679303
    [Abstract] [Full Text] [Related]

  • 32. Determination of fluoxetine and norfluoxetine in plasma by gas chromatography with electron-capture detection.
    Nash JF, Bopp RJ, Carmichael RH, Farid KZ, Lemberger L.
    Clin Chem; 1982 Oct 04; 28(10):2100-2. PubMed ID: 6982125
    [Abstract] [Full Text] [Related]

  • 33. Chiral high-performance liquid chromatographic analysis of fluoxetine and norfluoxetine in rabbit plasma, urine, and vitreous humor using an acetylated beta-cyclodextrin column.
    Yee L, Wong SH, Skrinska VA.
    J Anal Toxicol; 2000 Oct 04; 24(7):651-5. PubMed ID: 11043675
    [Abstract] [Full Text] [Related]

  • 34. Sensitive micromethod for column liquid chromatographic determination of fluoxetine and norfluoxetine in human plasma.
    Thomare P, Wang K, Van Der Meersch-Mougeot V, Diquet B.
    J Chromatogr; 1992 Dec 02; 583(2):217-21. PubMed ID: 1478986
    [Abstract] [Full Text] [Related]

  • 35. Determination of fluoxetine in plasma by gas chromatography-mass spectrometry using stir bar sorptive extraction.
    Fernandes C, Van Hoeck E, Sandra P, Lanças FM.
    Anal Chim Acta; 2008 May 05; 614(2):201-7. PubMed ID: 18420052
    [Abstract] [Full Text] [Related]

  • 36. Issues in methodology and applications for therapeutic drug monitoring of fluoxetine and norfluoxetine enantiomers.
    Zuccaro P, Pacifici R, Altieri I, Avenoso A, Pellegrini M, Spina E, Perucca E, Pichini S.
    Ther Drug Monit; 1998 Feb 05; 20(1):20-4. PubMed ID: 9485549
    [Abstract] [Full Text] [Related]

  • 37. Three-phase, liquid-phase microextraction combined with high performance liquid chromatography-fluorescence detection for the simultaneous determination of fluoxetine and norfluoxetine in human plasma.
    de Freitas DF, Porto CE, Vieira EP, de Siqueira ME.
    J Pharm Biomed Anal; 2010 Jan 05; 51(1):170-7. PubMed ID: 19683889
    [Abstract] [Full Text] [Related]

  • 38. Determination of human plasma levels of levo-alpha-acetylmethadol and its metabolites by gas chromatography-mass spectrometry.
    Eap CB, Bouchoux G, Scherbaum N, Gastpar M, Powell Golay K, Baumann P.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun 05; 805(1):141-6. PubMed ID: 15113550
    [Abstract] [Full Text] [Related]

  • 39. Enantiomeric separation of fluoxetine and norfluoxetine in plasma and serum samples with high detection sensitivity capillary electrophoresis.
    Desiderio C, Rudaz S, Raggi MA, Fanali S.
    Electrophoresis; 1999 Nov 05; 20(17):3432-8. PubMed ID: 10608711
    [Abstract] [Full Text] [Related]

  • 40. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
    Koran LM, Cain JW, Dominguez RA, Rush AJ, Thiemann S.
    Am J Psychiatry; 1996 Nov 05; 153(11):1450-4. PubMed ID: 8890679
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.